DAL
70
-4
GWW
46
7
AA
28
-9
TAP
40
5
KMI
67
2
URI
33
5
A
54
3
JNJ
39
7
NWSA
63
5
CI
35
3
PSX
30
6
WMT
67
-3
AN
55
5
EL
33
3
AAP
27
-3
XRAY
28
5
ESS
51
11
BBY
56
3
AZO
50
-2
WDC
37
-3
DAL
70
-4
GWW
46
7
AA
28
-9
TAP
40
5
KMI
67
2
URI
33
5
A
54
3
JNJ
39
7
NWSA
63
5
CI
35
3
PSX
30
6
WMT
67
-3
AN
55
5
EL
33
3
AAP
27
-3
XRAY
28
5
ESS
51
11
BBY
56
3
AZO
50
-2
WDC
37
-3
Financhill
Back

Mirum Pharmaceuticals Vs. Intra-Cellular Therapies Industry Stock Comparison

Buy
54

MIRM
Mirum Pharmaceuticals

Last Price:
$43.36
Seasonality Move:
10.4%
Buy
61

ITCI
Intra-Cellular Therapies

Last Price:
$126.86
Seasonality Move:
2.9%
Buy
54
Mirum Pharmaceuticals (MIRM) is a Buy

Is Mirum Pharmaceuticals a Buy, Sell or Hold?

  • The current Mirum Pharmaceuticals [MIRM] share price is $43.32. The Score for MIRM is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • MIRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Intra-Cellular Therapies (ITCI) is a Buy

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $126.89. The Score for ITCI is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • ITCI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MIRM Stock Price Chart

What is Mirum Pharmaceuticals's stock price today?

  • The Mirum Pharmaceuticals share price today is $43.32
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIRM is experiencing selling pressure, which indicates risk of future bearish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $126.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.

MIRM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 54.28 Buy
Chaikin Money Flow: -781328 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.36 - 43.38) Buy
Bollinger Bands (100): (39.42 - 43.62) Buy

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.34 Buy
Relative Strength Index (14 RSI): 87.18 Buy
Chaikin Money Flow: -9953478 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.29 - 99.79) Buy
Bollinger Bands (100): (72.19 - 89.87) Buy

MIRM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.58 Buy
20-day SMA: 42.07 Buy
50-day SMA: 42.83 Buy
200-day SMA: 36.12 Buy
8-day EMA: 42.62 Buy
20-day EMA: 42.49 Buy
50-day EMA: 42.26 Buy
200-day EMA: 37.73 Buy

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 95.56 Buy
20-day SMA: 89.05 Buy
50-day SMA: 87.32 Buy
200-day SMA: 76.32 Buy
8-day EMA: 102.15 Buy
20-day EMA: 92.65 Buy
50-day EMA: 87.08 Buy
200-day EMA: 77.64 Buy

Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $2.04 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and an increase next year of $3.13 per share.

Mirum Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):